A. Arezki

发表

Oncological safety and functional outcomes of testosterone replacement therapy in symptomatic adult-onset hypogonadal prostate cancer patients following robot-assisted radical prostatectomy

K. Zorn, D. Elterman, A. Zakaria, 2020, World Journal of Urology.

Reasons to believe in vaporization: a review of the benefits of photo-selective and transurethral vaporization

K. Zorn, D. Elterman, H. Cash, 2020, World Journal of Urology.

Safety and efficacy of GreenLight PVP in octogenarians: evaluation of the Global GreenLight Group database

F. Bruyère, L. Cindolo, V. Misrai, 2022, World Journal of Urology.

Reasons to overthrow TURP: bring on Aquablation

C. Roehrborn, K. Zorn, V. Misrai, 2020, World Journal of Urology.

Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database

F. Bruyère, L. Cindolo, V. Misrai, 2022, World Journal of Urology.

Impact of the presence of a median lobe on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of the Global Greenlight Group (GGG) Database

F. Bruyère, L. Cindolo, K. Zorn, 2021, World Journal of Urology.

Reasons to go for Rezūm steam therapy: an effective and durable outpatient minimally invasive procedure

C. Roehrborn, K. McVary, K. Zorn, 2020, World Journal of Urology.

Safety and efficacy of GreenLight PVP in octogenarians: evaluation of the Global GreenLight Group database

F. Bruyère, L. Cindolo, V. Misrai, 2023, World Journal of Urology.

Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate volumes 50-80 mL.

B. Helfand, V. Misrai, B. Chughtai, 2023, The Canadian journal of urology.

Aquablation® in patients on antithrombotics: Assessment of safety, post-operative bleeding rates and clinical outcomes.

C. Roehrborn, G. Badlani, P. Gilling, 2023, Urology.